Assay combines microfluidics and next-generation sequencing to reveal more mutations than existing tests
A new diagnostic test developed at A*STAR is helping researchers around the world identify gene mutations that put people at risk of severe eczema and other chronic skin diseases.
Aug 30, 2018
0
0